Clarus Therapeutics Holdings Inc. Made Headway

Fri, Sep 02, 2022 at 07:20 PM
Clarus Therapeutics Holdings Inc. Made Headway

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) shot up at $0.07, representing a gain of 35.3%. The stock appeared on our News Catalysts scanner on Thu, Aug 18, 2022 at 07:04 PM in the 'EARNINGS' category. From Fri, Aug 19, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Aug 26, 2022 at $0.27 with a volume of 12M+.

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.